Calista Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Nayagarh, Orissa, India, established in 2020.
2020 Nayagarh, Orissa, India Active
Last Updated:
Access Report
About Calista Pharmaceuticals Private Limited

Calista Pharmaceuticals Private Limited, a active private limited company, was established on 22 July 2020 in Nayagarh, Orissa, India. Engaging in specialty within the trading sector, it holds CIN: U51909OR2020PTC033520. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Dilip Kumar Das (Additional Director), Rajendra Kumar Karna (Director). Past directors included Runnu Jha, Pradyumna Kumar Nayak. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at C/O Pradyumna Ku Nayak, Nayagarh Itamati, Nayagarh, Orissa, 752068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909OR2020PTC033520

  • Registration Number

    033520

  • Incorporation Date

    22 July 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** 19.97%
  • Profit Growth **** 33.46%
  • Ebitda **** 48.60%
  • Net Worth -32.39%
  • Total Assets **** 19.17%
Company report

Calista Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Calista Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Calista Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilip Kumar Das Additional Director 19 Oct 2022 Current
Rajendra Kumar Karna Director 22 Jul 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Oct 2022 Past
Pramod Abcsdd Director 20 Dec 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Calista Pharmaceuticals.

Calista Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.97% increase. The company also saw a substantial improvement in profitability, with a 33.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.39%.

Calista Pharmaceuticals revenue growth over time
Calista Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.97%
*******
*******
*******
*******
Revenue from Operations
*******
 19.97%
*******
*******
*******
*******
Total Assets
*******
 19.17%
*******
*******
*******
*******
Profit or Loss
*******
 33.46%
*******
*******
*******
*******
Net Worth
*******
 -32.39%
*******
*******
*******
*******
EBITDA
*******
 48.60%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Calista Pharmaceuticals?

Unlock access to Calista Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Calista Pharmaceuticals?

Calista Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Calista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calista Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Calista Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Dilip Kumar Das was appointed as a Additional Director was appointed as a Additional Director on 19 Oct 2022 & has been associated with this company since 3 years 3 months . was completed.

  • Annual General Meeting

    Calista Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Calista Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Cuttack. was documented.

  • Director Appointment

    Rajendra Kumar Karna was appointed as a Director was appointed as a Director on 22 Jul 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Calista Pharmaceuticals Private Limited was registered on 22 Jul 2020 with Roc Cuttack & aged 5 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Calista Pharmaceuticals Private Limited?

The CIN of Calista Pharmaceuticals Private Limited is U51909OR2020PTC033520.

Where is Calista Pharmaceuticals Private Limited headquartered?

Calista Pharmaceuticals Private Limited is headquartered at C/O Pradyumna Ku Nayak, Nayagarh Itamati, Nayagarh, Orissa, 752068.

When was Calista Pharmaceuticals Private Limited incorporated?

Calista Pharmaceuticals Private Limited was incorporated on 22 July 2020.

Who are the current directors of Calista Pharmaceuticals Private Limited?

The current directors of Calista Pharmaceuticals Private Limited are

What is the primary industry of Calista Pharmaceuticals Private Limited?

The primary industry of Calista Pharmaceuticals Private Limited is Trading.

Is Calista Pharmaceuticals Private Limited a listed company?

Calista Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Calista Pharmaceuticals Private Limited?

The authorized capital of Calista Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available